Pulmonary Edema Management

Introduction to Steroid Use

Steroids are not recommended for routine use in patients with pulmonary edema due to insufficient evidence and potential worsening of outcomes, as stated by the American Journal of Respiratory and Critical Care Medicine and the Cystic Fibrosis Foundation 1
The American Journal of Respiratory and Critical Care Medicine concludes that there is insufficient evidence to support routine corticosteroid use in acute exacerbations of pulmonary disease 1

Primary management of pulmonary edema involves treating the underlying cardiac cause with diuretics, vasopressors, and inotropes (such as dobutamine or milrinone) to reduce fluid overload, maintain coronary perfusion, and increase left ventricular contractility, as recommended by the American Journal of Obstetrics and Gynecology 2

Short-course systemic corticosteroids (e.g., prednisolone 30 mg/day) may be beneficial in COPD exacerbations with pulmonary edema, according to Thorax 3
Intravenous methylprednisolone (125 mg three times daily) may be considered in cases of nerve agent exposure with pulmonary edema, as stated by Anesthesiology (ASA) 4
Corticosteroids may be considered in patients with ventilator-associated pneumonia who present with refractory septic shock, especially those with elevated inflammatory markers, according to the Society of Critical Care Medicine guidelines 5
Patients with severe COPD exacerbation, croup in pediatric patients, or severe allergic component with URI may be considered for steroid therapy, as recommended by guidelines 6

Steroids are not recommended for routine use in cases of amniotic fluid embolism-related pulmonary edema, according to the American Journal of Obstetrics and Gynecology 2
Steroids should be avoided in patients with cardiogenic pulmonary edema, as there is no evidence supporting their use, and they may potentially worsen outcomes 1
Patients with active viral infections, bacterial infections without appropriate antibiotic coverage, and systemic fungal infections should avoid steroids, as they may worsen infection or cause significant harm 7, 8
Patients with uncontrolled diabetes or immunocompromised state should avoid steroids, as recommended by guidelines 7, 9

If steroids are used, the lowest effective dose for the shortest duration should be used, with monitoring of fluid balance, blood glucose, electrolytes, and signs of infection 1
Systemic steroids should be avoided in patients with uncomplicated viral upper respiratory infections, as they may cause significant harm through immunosuppression and delayed viral clearance, according to the American Academy of Otolaryngology-Head and Neck Surgery 7, 8
Patients taking prednisone equivalent ≥20 mg daily should defer non-live attenuated vaccinations (except influenza) until steroids are tapered to <20 mg daily, due to increased infection risk, as recommended by guidelines 9
Metilprednisolona 0.5 mg/kg IV every 12 hours for 5 days, prednisona 50 mg daily orally, or hidrocortisona 200-300 mg/day may be used in specific cases, as recommended by the Society of Critical Care Medicine guidelines and the Infectious Diseases Society of America guidelines 5, 10

Appropriate antibiotic therapy based on severity and risk factors is recommended, as supported by the European Respiratory Society and other guidelines 11
Early mobilization of all patients is recommended, and low molecular weight heparin is recommended for patients with acute respiratory failure 11, 12
Consideration of non-invasive ventilation is recommended, particularly in patients with chronic obstructive pulmonary disease and pneumonia 12
Monitoring response using clinical parameters (temperature, respiratory rate, oxygenation) is recommended, and measuring C-reactive protein on days 1 and 3-4 for patients with unfavorable clinical parameters is suggested 11
The American Thoracic Society recommends against routine use of corticosteroids in adults with nonsevere community-acquired pneumonia (strong recommendation, high quality evidence) and suggests against routine use in adults with severe community-acquired pneumonia (conditional recommendation, moderate quality evidence) 13
The Surviving Sepsis Campaign recommendations for corticosteroid use are endorsed for patients with refractory septic shock 13